Sbarro Health Research Organization

‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers

sbarro-institute-temple-shro-childhood-cancer

‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers Post & News admin July 18, 2022 Editorial by Prof. Philip Landrigan, Director of the Global Public Health Programme, published in the second issue of Annals of Research in Oncology Newswise — A multi-disciplinary, “One Health” approach to cancer research is necessary… Continue reading ‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers

VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review

shro-sbarro-institute-and-vr-for-patients

VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review Post & News admin July 9, 2022 Newswise press release — Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.  Published in the journal Cancers,… Continue reading VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review

(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma

shro-mesothelioma-mpm-antonio-giordano

(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma Post & News admin June 30, 2022 Newswise — A group of researchers including Antonio Giordano, M.D., Ph.D., Director and Founder of the Sbarro Health Research Organization (SHRO), Temple University, in collaboration with Stefano Landi, Ph.D.,. Chair of Genetics at University of Pisa, Italy, have identified… Continue reading (SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma

Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology

shro-sbarro-institute-mesothelioma

Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology Post & News admin June 28, 2022 Original Newswise post There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical… Continue reading Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology

Sbarro Health Research Organization (SHRO) Arrives in Campania

Professor Antonio Giordano, MD, Phd, President - SHRO and Giancarlo Arra, Vice President - SHRO

Sbarro Health Research Organization (SHRO) Arrives in Campania Post & News admin June 20, 2022 Professor Antonio Giordano, MD, Phd, President – SHRO and Giancarlo Arra, Vice President – SHRO   “If I have seen further it is by standing on the shoulders of Giants” – Sir Isaac Newton (in a letter to Robert Hooke,… Continue reading Sbarro Health Research Organization (SHRO) Arrives in Campania